Catalyst Pharmaceuticals Inc (CPRX)

followers · Follow

Sector:	HEALTH CARE
Industry:	PHARMACEUTICALS
SIC:	PHARMACEUTICAL PREPARATIONS
CEO:	Patrick J. McEnany
Employees:	80
Web site:	catalystpharma.com
355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL, 33134 (305) 529-2522

Catalyst Pharmaceutical Partners Inc

	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change

Catalyst Pharmaceuticals, Inc. focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS) and Ruzurgi.

Please log in first to see chart

Catalyst Pharmaceuticals Inc YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Shareholders (13F, 13D/G)

Current Mutual Fund/ETF Holders

Active 13D/G Filings

SEC Filings

Insiders

Short Positions

Congress

Proposed Sales

Comments and Updates

To Excel | To CSV | To TSV

Investor	History	Shares Held or Principal Amt	Market Value	% of Portfolio	Previous % of Portfolio	Rank	Change in Shares	% Change in Shares	% Ownership	Qtr 1st Owned	Est. Avg Price	Source	Source Date	Date Reported
No data available